Submitted Successfully!
To reward your contribution, here is a gift for you: A free trial for our video production service.
Thank you for your contribution! You can also upload a video entry or images related to this topic.
Version Summary Created by Modification Content Size Created at Operation
1 + 404 word(s) 404 2020-12-15 07:49:51

Video Upload Options

Do you have a full video?


Are you sure to Delete?
If you have any further questions, please contact Encyclopedia Editorial Office.
Li, V. CYP7B1 Gene. Encyclopedia. Available online: (accessed on 22 June 2024).
Li V. CYP7B1 Gene. Encyclopedia. Available at: Accessed June 22, 2024.
Li, Vivi. "CYP7B1 Gene" Encyclopedia, (accessed June 22, 2024).
Li, V. (2020, December 23). CYP7B1 Gene. In Encyclopedia.
Li, Vivi. "CYP7B1 Gene." Encyclopedia. Web. 23 December, 2020.
CYP7B1 Gene

Cytochrome P450 Family 7 Subfamily B Member 1


1. Normal Function

The CYP7B1 gene is a member of the cytochrome P450 gene family. Enzymes produced from cytochrome P450 genes are involved in the formation and breakdown of various molecules and chemicals within cells. The CYP7B1 gene provides instructions for making an enzyme called oxysterol 7-alpha-hydroxylase. This enzyme is produced primarily in the liver and the brain. In the liver, oxysterol 7-alpha-hydroxylase is involved in the pathway that breaks down a waxy, fat-like substance called cholesterol to form a bile acid called chenodeoxycholic acid. Bile acids are a component of a digestive fluid called bile that digests fats.

In the brain, oxysterol 7-alpha-hydroxylase is also involved in a pathway that converts cholesterol to hormones called neurosteroids. Neurosteroids increase nerve cell activity (excitability) and promote cell survival and communication between nerve cells. The enzyme primarily converts the neurosteroid dehydroepiandrosterone (DHEA) into 7-hydroxy-DHEA. Oxysterol 7-alpha-hydroxylase helps maintain normal cholesterol levels in the brain and, by producing neurosteroids through altering existing hormones within the pathway, regulates the effects of neurosteroids on the brain.

2. Health Conditions Related to Genetic Changes

2.1 Spastic Paraplegia Type 5A

At least 37 mutations in the CYP7B1 gene have been found to cause spastic paraplegia type 5A. This condition is characterized by muscle stiffness (spasticity) and severe weakness of the lower limbs (paraplegia), typically beginning in adolescence. Most CYP7B1 gene mutations change single protein building blocks (amino acids) in the oxysterol 7-alpha-hydroxylase enzyme. Such changes reduce the enzyme's activity. Other mutations result in a complete loss of functional enzyme.

Reduced oxysterol 7-alpha-hydroxylase enzyme activity does not seem to affect cholesterol breakdown or bile acid production in the liver. Another pathway in the liver can perform these functions, which may explain why reduction of oxysterol 7-alpha-hydroxylase activity does not impact liver function.

In the brain, a decrease in enzyme activity results in an accumulation of cholesterol and alters neurosteroid production triggered by oxysterol 7-alpha-hydroxylase. Abnormal levels of neurosteroids impairs cell survival, likely leading to nerve cell death. The abnormal buildup of cholesterol in the brain probably also contributes to the death of nerve cells. The loss of these cells results in the deterioration of nervous system functions (neurodegeneration) and causes the movement problems, weakness, and other signs and symptoms characteristic of spastic paraplegia type 5A.

3. Other Names for This Gene

  • CBAS3

  • CP7B

  • cytochrome P450 7B1

  • cytochrome P450, subfamily VIIB (oxysterol 7 alpha-hydroxylase), polypeptide 1

  • oxysterol 7-alpha-hydroxylase


  1. Arnoldi A, Crimella C, Tenderini E, Martinuzzi A, D'Angelo MG, Musumeci O,Toscano A, Scarlato M, Fantin M, Bresolin N, Bassi MT. Clinical phenotypevariability in patients with hereditary spastic paraplegia type 5 associated withCYP7B1 mutations. Clin Genet. 2012 Feb;81(2):150-7. doi:10.1111/j.1399-0004.2011.01624.x.
  2. Goizet C, Boukhris A, Durr A, Beetz C, Truchetto J, Tesson C, Tsaousidou M,Forlani S, Guyant-Maréchal L, Fontaine B, Guimarães J, Isidor B, Chazouillères O,Wendum D, Grid D, Chevy F, Chinnery PF, Coutinho P, Azulay JP, Feki I, Mochel F, Wolf C, Mhiri C, Crosby A, Brice A, Stevanin G. CYP7B1 mutations in pure andcomplex forms of hereditary spastic paraplegia type 5. Brain. 2009 Jun;132(Pt6):1589-600. doi: 10.1093/brain/awp073.
  3. Tsaousidou MK, Ouahchi K, Warner TT, Yang Y, Simpson MA, Laing NG, WilkinsonPA, Madrid RE, Patel H, Hentati F, Patton MA, Hentati A, Lamont PJ, Siddique T,Crosby AH. Sequence alterations within CYP7B1 implicate defective cholesterolhomeostasis in motor-neuron degeneration. Am J Hum Genet. 2008 Feb;82(2):510-5.doi: 10.1016/j.ajhg.2007.10.001.
Contributor MDPI registered users' name will be linked to their SciProfiles pages. To register with us, please refer to :
View Times: 313
Entry Collection: MedlinePlus
Revision: 1 time (View History)
Update Date: 23 Dec 2020
Video Production Service